Robert Lake
Senior Managing Director, Life Sciences @ Trinity Capital
San Diego, United States
Robert Lake is a venture - series unknown investor at Trinity Capital in San Diego focused on Health Care and Medical Device. Robert Lake is based out of San Diego, California, and is the senior managing director of life sciences of Trinity Capital. Robert previously worked at Runway Growth Capital as a managing director and head of life sciences.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 89%
Last updated:
For AI agents: llms.txt
Industries Robert Lake invests in
Stages Robert Lake invests in
Countries Robert Lake invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 8 (89%)
- Medical Device 7 (78%)
- Medical 5 (56%)
- Therapeutics 2 (22%)
- Pharmaceutical 2 (22%)
Stage
- Venture - Series Unknown 6 (67%)
- Post-IPO Debt 2 (22%)
- Debt Financing 1 (11%)
Country
- United States 8 (89%)
- United Kingdom 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Emboline is a medical device company with a game-changing device for total embolic protection during percutaneous heart valve repair and replacement procedures and other cardiovascular procedures with embolic risks. | $20M / Venture - Series Unknown / Mar 11, 2026 | ||
| Nalu Medical is an early-stage company that develops a range of medical devices. Their vision to modernize and improve the technology in medical devices, thus improving the lives of people.The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS)and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The company was founded in 2014 and is based in Carlsbad, California. | $50M / Venture - Series Unknown / Sep 16, 2025 | ||
| Rapid Micro Biosystems provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. It offers the Growth Direct System, a non-destructive method for microbial enumeration. The company was formerly known as Genomic Profiling Systems and changed its name to RapidMicro Biosystems in 2007. Rapid Micro Biosystems was founded in 2006 and is based in Bedford, Massachusetts. | $45M / Post-IPO Debt / Aug 12, 2025 | ||
| CMR Surgical develops and manufactures robotic surgical systems designed to enhance precision and efficiency in minimally invasive surgery. Its primary product, Versius, is a versatile and modular robotic system that supports various surgical procedures.Versius is designed to mimic the human arm's flexibility while offering a compact andergonomic design. It integrates with hospital workflows and provides data-driven insights to support surgical performance. CMR Surgical collaborates with healthcare professionals to ensure that its technology meets clinical needs and improves patient outcomes. | $200M / Venture - Series Unknown / Apr 02, 2025 | ||
| Neuros Medical is a neuromodulation company, is focused on developing proprietary therapies for the unmet needs of patients worldwide. The Company's patented platform technology, Electrical Nerve Block, is focused on the elimination of chronic pain in a variety of applications including neuroma/residual limb pain, chronic post-surgicalpain, and chronic migraine. | $25M / Venture - Series Unknown / Oct 31, 2023 | ||
| Revelle Aesthetics features a team of the brightest and most passionate minds in the medical device and aesthetics industries. It was born from ExploraMed, a leading medtech incubator. | $30M / Venture - Series Unknown / Jun 01, 2023 | ||
| RxAnte provides predictive analytics and targeted clinical programs that improve medication prescribing and adherence for health plans and their members. A significant component to these clinical programs is RxAnte’s Mosaic Pharmacy Service, which provides a superior pharmacy experience to a health plan’s most complex and vulnerable members whileworking with their prescribers and caregivers to make regimens safer, simpler, and more affordable. | $15M / Venture - Series Unknown / Dec 20, 2022 | ||
| Allurion Technologies is developing a medical device for weight loss that can be delivered and removed without surgery or endoscopy. | $25M / Debt Financing / Apr 06, 2021 | ||
| Ekso Bionics is committed to applying the latest technology and engineering to help people rethink current physical limitations and achieve the remarkable. Originally Berkeley Bionics, Ekso Bionics was founded in Berkeley, California in 2005. Since inception Ekso Bionics has forged partnerships with world-class institutions like UC Berkeley,received research grants from the Department of Defense and licensed technology to the Lockheed Martin Corporation. Today Ekso Bionics continues to pioneer the field of exoskeletons, designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human mobility and capability. | $10M / Post-IPO Debt / Jan 06, 2017 |
Co-Investors
About Trinity Capital
Trinity Capital is a provider of venture debt and equipment financings to emerging growth-stage companies. They work closely with venture capital firms, tech banks, and their respective portfolio companies to provide insightful and competitive venture debt financing solutions to address their customers’ specific needs. Having funded some of theworld’s most innovative start-up companies, they are the partner of choice for venture-backed technology start-ups seeking access to capital while preserving equity.
Trinity Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Jason Hamlin
Director of Finance and Tax
|
|||
Kevin Zeidan
Managing Director
|
|||
Kyle Brown
Chief Investment Officer and President
|
|||
|
Robert Lake
Senior Managing Director, Life Sciences
|
|||
Trin Coleman
Associate, Finance & Investor Relations
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Robert Lake invest in?
Robert Lake invests primarily in Health Care, Medical Device and Medical startups, most often at Venture - Series Unknown and Post-IPO Debt stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Robert Lake?
Public channels for Robert Lake include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Robert Lake last invest?
The most recent investment recorded for Robert Lake closed in Mar 2026. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
